Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Clinical trial NCT07233720 · RECRUITING
Trial details
- NCT number
- NCT07233720
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-11-18
- Primary completion
- 2028-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.